News

Inspicos achieves major win at the EPO

During oral proceedings before the EPO’s Boards of Appeal on 23 February 2017, Inspicos obtained a major win on behalf of a leading international manufacturer of healthcare devices. The oral proceedings concluded more than 10 years of opposition and appeal. On the client’s behalf, Inspicos successfully defended the validity of the opposed patent on the ...

read more

UK to ratify UPC agreement

Jakob Pade Frederiksen reports. Following the Brexit referendum in June 2016, the future fate of the Unitary Patent (UP) and the Unified Patent Court (UPC) has been uncertain. To the surprise of many, the UK Government, however, announced on 28 November 2016 that it intends to proceed with preparations to ratify the Unified Patent Court ...

read more

Anna Lövqvist appointed a partner

We proudly announce that European Patent Attorney Anna Lövqvist is now a shareholder and partner at Inspicos P/S. Anna joined Inspicos as an associate in 2009. Being part of the Biotechnology and Chemistry group, she primarily advises innovator companies in the field of biotechnology and biopharmaceuticals, working, e.g., with patenting and freedom-to-operate analyses of immunotherapeutic ...

read more

Ranking results 2017

In the 2017 edition of Managing Intellectual Property’s World IP Survey, Inspicos has for the tenth year in a row been ranked in Tier 1. MIP’s survey is a qualitative ranking based on comprehensive analyses and a high number of interviews of clients, competitors and partners, and further based on each firm’s track record. The ...

read more

What does Brexit mean to your IP in Europe?

Ulla Klinge reports. The short answer is there is no immediate impact. Following the referendum result the British Parliament will now consider how and when to proceed. The UK’s exit from the EU will be negotiated over at least the next two years, and during that time the UK will remain a member of the ...

read more